Metraipolis › archive › dc_b375a3fd331a

[225Ac]Ac-labeled matuzumab is an effective radioimmunotherapeutic against EGFR-positive triple negative breast cancer — Europe PMC PMID:41546059

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41546059
DOI: 10.1186/s13058-[numero omesso]-z
License (as archived): solo-consultazione
Archived: 2026-11-06T18:06:14.989Z
SHA-256 of the archived text: 3fc04d761183049ed56094f0a8314585390447601540c5bd348bfe90486d0621
Stable URL of this page: https://metraipolis.com/documento/dc_b375a3fd331a

How to cite

[225Ac]Ac-labeled matuzumab is an effective radioimmunotherapeutic against EGFR-positive triple negative breast cancer — Europe PMC PMID:41546059 — Europe PMC (en), https://europepmc.org/article/MED/41546059 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b375a3fd331a (Metraipolis archive dc_b375a3fd331a, sha256 3fc04d761183049ed56094f0a8314585390447601540c5bd348bfe90486d0621)

BibTeX

@misc{dcb375a3fd331a,
  title = {[225Ac]Ac-labeled matuzumab is an effective radioimmunotherapeutic against EGFR-positive triple negative breast cancer — Europe PMC PMID:41546059},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41546059},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b375a3fd331a; sha256 3fc04d761183049ed56094f0a8314585390447601540c5bd348bfe90486d0621},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41546059. Agents can read the archived copy with the MCP tool read_document.